Categories
Cardiovascular
Diagnostics
Endocrinology
Health Insurance
Medical Devices
Mental Health
Nutrition
Oncology
Public Health
Sexual Health
Popular Articles
Stretch Mark Remedies

Studies Show AFRESA(R) Controls Post-Meal Sugar Levels With Less Weight Gain And Hypoglycemia Risk For Diabetes Patients
The findings of two 52-week studies show that the investigational ultra rapid acting insulin AFRESA® (insulin human [rDNA origin]) Inhalation Powder combined with basal insulin is comparable to standard of care therapies in controlling post-meal blood sugar levels, and also results in significantly less weight gain and risk of hypoglycemia for adult patients with diabetes. The data were presented at the American Diabetes Association"s 69th Scientific Sessions.
generic viagra online
Spanish Study Finds Bullies Have Harassed 14 Percent Of Workers Over Past 6 Months
Although it is a relatively widespread phenomenon, the experts have still not been able to come up with an all-encompassing and precise definition of workplace abuse or bullying. Basing their work on previous literature, David González, of the High Court of Justice of Madrid and José Luís Graña, of the Faculty of Psychology at the Complutense University, have defined it in their study as a "process of systematic and repeated aggression by a person or group towards a workmate, subordinate or superior". Their research has been published in the latest issue of Psicothema.
News of the day
Acura And King Receive FDA Complete Response Letter Regarding Acurox(R)
Acura Pharmaceuticals, Inc. (Nasdaq: ACUR) and King Pharmaceuticals, Inc. (NYSE: KG) announced today that the U.S. Food and Drug Administration (FDA) has issued a Complete Response Letter regarding the New Drug Application (NDA) for Acurox (oxycodone HC1, USP and niacin, USP) Tablets CII, an immediate release product intended for the relief of moderate-to-severe pain.
Medical Devices

Management Agreement With The International Society Of Therapeutic Ultrasound Announced By AIUM

The American Institute of Ultrasound in Medicine (AIUM) has reached a management agreement with the International Society for Therapeutic Ultrasound (ISTU) effective July 1, 2009. The AIUM will support the ISTU"s administrative, financial, and member service functions in an effort to maximize the ISTU"s mission of advancing therapeutic ultrasound applications worldwide. "The AIUM recognizes therapeutic ultrasound as a rapidly expanding area of medical ultrasound," says AIUM President Harvey Nisenbaum, MD. "With a diverse membership in the medical ultrasound community, the AIUM is positioned to promote education and research in therapeutic ultrasound by cultivating the exchange of information among basic scientists, sonographers, and physicians." In April 2009, the AIUM established the Therapeutic Ultrasound Community of Practice, a membership subgroup dedicated to promoting therapeutic ultrasound by assisting in the development of educational programs and providing an opportunity for networking and collaboration. "I think that collaboration between the ISTU and the AIUM can greatly expand awareness of therapeutic ultrasound applications and facilitate growth of our organization," says ISTU President Kullervo Hynynen, PhD. The AIUM has managed several nonprofit medical associations and currently has a management arrangement with the World Federation for Ultrasound in Medicine and Biology. The potential benefits of therapeutic ultrasound are recognized for targeted drug delivery, pathogenic tissue destruction, physical therapy, and several other applications. Jennifer Hilderbrand American Institute of Ultrasound in Medicine


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):

© Copyright 2009